The increasing incidence of carbapenem-resistant Klebsiella pneumoniae (CRKP) strains is considered as a terrifying public health concern. This study target was to gain a further insight into the virulence traits of CRKP isolates in Egypt. The study was carried out by using 43 clinical K. pneumoniae isolates. Antibiotic susceptibility testing, biofilm formation assay, and molecular characterization of carbapenemase and virulence genes were done for all isolates. In addition, the genotypic relationship between CRKP isolates was identified by using enterobacterial repetitive intergenic consensus-polymerase chain reactions (ERIC-PCRs). A Galleria mellonella survival assay was adopted for in vivo testing of virulence of the CRKP. Carbapenem resistance was exhibited among 58% (25/43) isolates. Minimum inhibitory concentration values of carbapenem-resistant K. pneumoniae (CRKP) ranged from 32 to 128 μg/mL. Biofilm assay has revealed that 21 isolates (49%) had moderate biofilm formation and 11 isolates (25.5%) were strong biofilm producers. BlaNDM-1 was recognized in 20.9% (9/43) of the isolates, while blaOXA-48 was observed in 18.5% (8/43). Type 3 fimbriae (mrkD) and entB were addressed among 72.1% and 62.8% of K. pneumoniae isolates, respectively. The ybtS and iutA genes were detected among 44.2% and 37.2% of the isolates, respectively. ERIC-PCR showed 23 genetic profiles among CRKP isolates. CRKP biofilm producers were virulent according to the G. mellonella model, which indicates the importance of biofilm as a virulence trait among CRKP. This study indicates the emergence of CRKP with increased virulence traits, especially biofilm formation, in Egypt. This alarming report highlights the ongoing need for effective screening procedures and strict infection control measures.
Get full access to this article
View all access options for this article.
References
1.
KangC.I., KimS.H., BangJ.W., KimH.B., KimN.J., KimE.C., OhM.D., and ChoeK.W.. 2006. Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance. J. Korean Med. Sci. 21:816–822.
2.
ZhaoJ., ChenJ., ZhaoM., QiuX., ChenX., ZhangW., SunR., OgutuJ.O., and ZhangF.. 2016. Multilocus sequence types and virulence determinants of hypermucoviscosity-positive Klebsiella pneumoniae isolated from community-acquired infection cases in Harbin, North China. Jpn. J. Infect. Dis. 69:357–360.
3.
SchroederM., BrooksB.D., and BrooksA.E.. 2017. The complex relationship between virulence and antibiotic resistance. Genes (Basel), 8:39.
4.
NordmannP., NaasT., and PoirelL.. 2011. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791–1798.
5.
ProkeschB.C., TeKippeM., KimJ., RajP., TeKippeE.M., and GreenbergD.E.. 2016. Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae. Lancet Infect. Dis. 16:e190–e195.
6.
ShonA.S., BajwaR.P., and RussoT.A.. 2013. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence, 4:107–118.
7.
VuottoC., LongoF., BaliceM.P., DonelliG., and VaraldoP.E.. 2014. Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens, 3:743–758.
8.
CortesG., BorrellN., de AstorzaB., GomezC., SauledaJ., and AlbertiS.. 2002. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect. Immun. 70:2583–2590.
9.
FungC.P., ChangF.Y., LeeS.C., HuB.S., KuoB.I., LiuC.Y., HoM., and SiuL.K.. 2002. A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis?. Gut. 50:420–424.
10.
YuW.L., KoW.C., ChengK.C., LeeH.C., KeD.S., LeeC.C., FungC.P., and ChuangY.C.. 2006. Association between rmpA and magA genes and clinical syndromes caused by Klebsiella pneumoniae in Taiwan. Clin. Infect. Dis. 42:1351–1358.
11.
KlemmP., and SchembriM.A.. 2000. Bacterial adhesins: function and structure. Int. J. Med. Microbiol. 290:27–35.
12.
HuangY.J., LiaoH.W., WuC.C., and PengH.L.. 2009. MrkF is a component of type 3 fimbriae in Klebsiella pneumoniae. Res. Microbiol. 160:71–79.
13.
HsiehP.F., LinT.L., LeeC.Z., TsaiS.F., and WangJ.T.. 2008. Serum-induced iron-acquisition systems and TonB contribute to virulence in Klebsiella pneumoniae causing primary pyogenic liver abscess. J. Infect. Dis. 197:1717–1727.
14.
BachmanM.A., OylerJ.E., BurnsS.H., CazaM., LepineF., DozoisC.M., and WeiserJ.N.. 2011. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect. Immun. 79:3309–3316.
15.
KhalilM.A.F., MoawadS.S., and HefzyE.M.. 2018. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model. J. Med. Microbiol. 68:52–59.
16.
Mac FaddinJ.F.2000. Biochemical Tests for Identification of Medical Bacteria. Lippincott Williams & Wilkins, Philadelphia.
17.
CLSI. 2014. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard. Document M2-A11. 11th ed. CLSI, Wayne, PA.
18.
YuV.L., HansenD.S., KoW.C., SagnimeniA., KlugmanK.P., von GottbergA., GoossensH., WagenerM.M., BenediV.J., and International Klebseilla Study Group. 2007. Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg. Infect. Dis. 13:986–993.
StepanovicS., CirkovicI., RaninL., and Svabic-VlahovicM.. 2004. Biofilm formation by Salmonella spp. and Listeria monocytogenes on plastic surface. Lett. Appl. Microbiol. 38:428–432.
21.
PoirelL., WalshT.R., CuvillierV., and NordmannP.. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119–123.
22.
CompainF., BabosanA., BrisseS., GenelN., AudoJ., AilloudF., Kassis-ChikhaniN., ArletG., and DecreD.. 2014. Multiplex PCR for detection of seven virulence factors and K1/K2 capsular serotypes of Klebsiella pneumoniae. J. Clin. Microbiol. 52:4377–4380.
23.
DuanH., ChaiT., LiuJ., ZhangX., QiC., GaoJ., WangY., CaiY., MiaoZ., YaoM., and SchlenkerG.. 2009. Source identification of airborne Escherichia coli of swine house surroundings using ERIC-PCR and REP-PCR. Environ. Res. 109:511–517.
24.
InsuaJ.L., LlobetE., MorantaD., Perez-GutierrezC., TomasA., GarmendiaJ., and BengoecheaJ.A.. 2013. Modeling Klebsiella pneumoniae pathogenesis by infection of the wax moth Galleria mellonella. Infect. Immun. 81:3552–3565.
25.
CartelleM., del Mar TomasM., PertegaS., BeceiroA., DominguezM.A., VelascoD., MolinaF., VillanuevaR., and BouG.. 2004. Risk factors for colonization and infection in a hospital outbreak caused by a strain of Klebsiella pneumoniae with reduced susceptibility to expanded-spectrum cephalosporins. J. Clin. Microbiol. 42:4242–4249.
26.
PaczosaM.K., and MecsasJ.. 2016. Klebsiella pneumoniae: Going on the offense with a strong defense. Microbiol. Mol. Biol. Rev. 80:629–661.
27.
Centers for Disease Control and Prevention. 2013. Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb. Mortal. Wkly. Rep. 62:165–170.
28.
WasfiR., ElkhatibW.F., and AshourH.M.. 2016. Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals. Sci. Rep. 6:38929.
29.
RossoliniG.M.2015. Extensively drug-resistant carbapenemase-producing Enterobacteriaceae: an emerging challenge for clinicians and healthcare systems. J. Intern. Med. 277:528–531.
30.
ChenL., MathemaB., ChavdaK.D., DeLeoF.R., BonomoR.A., and KreiswirthB.N.. 2014. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 22:686–696.
31.
HoltK.E., WertheimH., ZadoksR.N., BakerS., WhitehouseC.A., DanceD., JenneyA., ConnorT.R., HsuL.Y., SeverinJ., BrisseS., CaoH., WilkschJ., GorrieC., M.B.Schultz, EdwardsD.J., NguyenK.V., NguyenT.V., DaoT.T., MensinkM., MinhV.L., NhuN.T., SchultszC., KuntamanK., NewtonP.N., MooreC.E., StrugnellR.A., and ThomsonN.R.. 2015. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl. Acad. Sci. U S A. 112:E3574–E3581.
32.
KhalilM.A.F., ElgamlA., and El-MowafyM.. 2017. Emergence of multidrug-resistant New Delhi metallo-beta-lactamase-1-producing Klebsiella pneumoniae in Egypt. Microb. Drug Resist. 23:480–487.
33.
KhalifaH.O., SolimanA.M., AhmedA.M., ShimamotoT., and ShimamotoT.. 2016. NDM-4- and NDM-5-Producing Klebsiella pneumoniae Coinfection in a 6-Month-Old Infant. Antimicrob. Agents Chemother. 60:4416–4417.
34.
AbdelazizM.O., BonuraC., AleoA., FascianaT., and MamminaC.. 2013. NDM-1- and OXA-163-producing Klebsiella pneumoniae isolates in Cairo, Egypt, 2012. J. Glob. Antimicrob. Resist. 1:213–215.
35.
Uz ZamanT., AldreesM., Al JohaniS.M., AlrodayyanM., AldughashemF.A., and BalkhyH.H.. 2014. Multi-drug carbapenem-resistant Klebsiella pneumoniae infection carrying the OXA-48 gene and showing variations in outer membrane protein 36 causing an outbreak in a tertiary care hospital in Riyadh, Saudi Arabia. Int. J. Infect. Dis. 28:186–192.
36.
AndersonK.F., LonswayD.R., RasheedJ.K., BiddleJ., JensenB., McDougalL.K., CareyR.B., ThompsonA., StockerS., LimbagoB., and PatelJ.B.. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45:2723–2725.
37.
VasaikarS., ObiL., MorobeI., and Bisi-JohnsonM.. 2017. Molecular characteristics and antibiotic resistance profiles of Klebsiella isolates in Mthatha, Eastern Cape Province, South Africa. Int. J. Microbiol. 2017:8486742.
38.
BinaM., PournajafA., MirkalantariS., TalebiM., and IrajianG.. 2015. Detection of the Klebsiella pneumoniae carbapenemase (KPC) in K. pneumoniae isolated from the clinical samples by the phenotypic and genotypic methods. Iran J. Pathol. 10:199–205.
39.
GharrahM.M., Mostafa El-MahdyA., and BarwaR.F.. 2017. Association between virulence factors and extended spectrum beta-lactamase producing Klebsiella pneumoniae compared to nonproducing isolates. Interdiscip. Perspect. Infect. Dis. 2017:7279830.
40.
RussoT.A., OlsonR., FangC.T., StoesserN., MillerM., MacDonaldU., HutsonA., BarkerJ.H., La HozR.M., and JohnsonJ.R.. 2018. Identification of biomarkers for differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J. Clin. Microbiol. 56:776–781.
41.
ZhangY., ZhaoC., WangQ., WangX., ChenH., LiH., ZhangF., LiS., WangR., and WangH.. 2016. High prevalence of hypervirulent Klebsiella pneumoniae infection in China: geographic distribution, clinical characteristics, and antimicrobial resistance. Antimicrob. Agents Chemother. 60:6115–6120.
42.
SeifiK., KazemianH., HeidariH., RezagholizadehF., SaeeY., ShirvaniF., and HouriH.. 2016. Evaluation of biofilm formation among Klebsiella pneumoniae isolates and molecular characterization by ERIC-PCR. Jundishapur. J. Microbiol. 9:e30682.
43.
SchrollC., BarkenK.B., KrogfeltK.A., and StruveC.. 2010. Role of type 1 and type 3 fimbriae in Klebsiella pneumoniae biofilm formation. BMC Microbiol. 10:179.
44.
El Fertas-AissaniR., MessaiY., AlouacheS., and BakourR.. 2013. Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathol. Biol. (Paris). 61:209–216.
45.
MurphyC.N., MortensenM.S., KrogfeltK.A., and CleggS.. 2013. Role of Klebsiella pneumoniae type 1 and type 3 fimbriae in colonizing silicone tubes implanted into the bladders of mice as a model of catheter-associated urinary tract infections. Infect. Immun. 81:3009–3017.
46.
YangD., and ZhangZ.. 2008. Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum beta-lactamases. J. Hosp. Infect. 68:369–371.
47.
SubramanianP., ShanmugamN., SivaramanU., KumarS., and SelvarajS.. 2012. Antiobiotic resistance pattern of biofilm-forming uropathogens isolated from catheterised patients in Pondicherry, India. Australas. Med. J. 5:344–348.
48.
SanchezC.J.Jr., MendeK., BeckiusM.L., AkersK.S., RomanoD.R., WenkeJ.C., and MurrayC.K.. 2013. Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect. Dis. 13:47.
49.
FuurstedK., ScholerL., HansenF., DamK., BojerM.S., HammerumA.M., Dagnaes-HansenF., OlsenA., JasemianY., and StruveC.. 2012. Virulence of a Klebsiella pneumoniae strain carrying the New Delhi metallo-beta-lactamase-1 (NDM-1). Microbes Infect. 14:155–158.
50.
KoczuraR., and KaznowskiA.. 2003. Occurrence of the Yersinia high-pathogenicity island and iron uptake systems in clinical isolates of Klebsiella pneumoniae. Microb. Pathog. 35:197–202.
51.
Alcantar-CurielM.D., BlackburnD., SaldanaZ., Gayosso-VazquezC., IovineN.M., De la CruzM.A., and GironJ.A.. 2013. Multi-functional analysis of Klebsiella pneumoniae fimbrial types in adherence and biofilm formation. Virulence, 4:129–138.
52.
JungS.W., ChaeH.J., ParkY.J., YuJ.K., KimS.Y., LeeH.K., LeeJ.H., KahngJ.M., LeeS.O., LeeM.K., LimJ.H., LeeC.H., ChangS.J., AhnJ.Y., LeeJ.W., and ParkY.G.. 2013. Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea. Epidemiol. Infect. 141:334–340.
53.
LafeuilleE., DecreD., Mahjoub-MessaiF., BidetP., ArletG., and BingenE.. 2013. OXA-48 carbapenemase-producing Klebsiella pneumoniae isolated from Libyan patients. Microb. Drug Resist. 19:491–497.
54.
BeyrouthyR., RobinF., DabboussiF., MallatH., HamzeM., and BonnetR.. 2014. Carbapenemase and virulence factors of Enterobacteriaceae in North Lebanon between 2008 and 2012: evolution via endemic spread of OXA-48. J. Antimicrob. Chemother. 69:2699–2705.
55.
LavigneJ.P., CuzonG., CombescureC., BourgG., SottoA., and NordmannP.. 2013. Virulence of Klebsiella pneumoniae isolates harboring bla KPC-2 carbapenemase gene in a Caenorhabditis elegans model. PLoS One. 8:e67847.
